MD Mason

485 total citations
5 papers, 297 citations indexed

About

MD Mason is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, MD Mason has authored 5 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 1 paper in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in MD Mason's work include Testicular diseases and treatments (2 papers), Neuroblastoma Research and Treatments (1 paper) and Urologic and reproductive health conditions (1 paper). MD Mason is often cited by papers focused on Testicular diseases and treatments (2 papers), Neuroblastoma Research and Treatments (1 paper) and Urologic and reproductive health conditions (1 paper). MD Mason collaborates with scholars based in United Kingdom, Netherlands and Denmark. MD Mason's co-authors include R.T.D. Oliver, Nina Aass, Robert E. Coleman, Ronald de Wit, Hans von der Maase, John D. Graham, J. Nicholls, Martin Quibell, A. Horwich and Richard Allman and has published in prestigious journals such as The Lancet, British Journal of Cancer and Journal of the Royal Society of Medicine.

In The Last Decade

MD Mason

5 papers receiving 283 citations

Peers

MD Mason
Craig Nichols United States
Fadi W. Abdul Karim United States
AE Stenwig Norway
Stuart Hinton United States
P. Schmidt Germany
Alberto G. Ayala United States
Craig Nichols United States
MD Mason
Citations per year, relative to MD Mason MD Mason (= 1×) peers Craig Nichols

Countries citing papers authored by MD Mason

Since Specialization
Citations

This map shows the geographic impact of MD Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MD Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MD Mason more than expected).

Fields of papers citing papers by MD Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MD Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MD Mason. The network helps show where MD Mason may publish in the future.

Co-authorship network of co-authors of MD Mason

This figure shows the co-authorship network connecting the top 25 collaborators of MD Mason. A scholar is included among the top collaborators of MD Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MD Mason. MD Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Oliver, R.T.D., MD Mason, Hans von der Maase, et al.. (2005). Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. The Lancet. 366(9482). 293–300. 267 indexed citations
3.
Mason, MD, Richard Allman, & Martin Quibell. (1996). Adhesion Molecules in Melanoma—More than Just Superglue?. Journal of the Royal Society of Medicine. 89(7). 393–395. 13 indexed citations
4.
Adams, Mark B., et al.. (1995). High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patients. British Journal of Cancer. 72(3). 774–776. 5 indexed citations
5.
Mason, MD, J. Nicholls, & A. Horwich. (1991). The effect of carboplatin on renal function in patients with metastatic germ cell tumours. British Journal of Cancer. 63(4). 630–633. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026